Influence of obesity on tumour volume in patients with prostate cancer

BJU International

Volumn 109, Issue 5, 2012, Pages 678-684

  Capitanio, Umberto ^a   Suardi, Nazareno ^a   Briganti, Alberto ^a   Gallina, Andrea ^a   Abdollah, Firas ^a   Lughezzani, Giovanni ^a   Salonia, Andrea ^a   Freschi, Massimo ^a   Montorsi, Francesco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

body mass index; obesity; prostate cancer; tumour volume

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; GLEASON SCORE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; ORGAN GROWTH; ORGAN SIZE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; TERTIARY HEALTH CARE; TUMOR VOLUME; UNIVARIATE ANALYSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSTATIC NEOPLASMS; TUMOR BURDEN;

EID: 84857357463     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10453.x     Document Type: Article

References (30)

1. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M,. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78 (Pubitemid 351232031)
2. Buschemeyer WC III, Freedland SJ,. Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol 2007; 52: 331-43 (Pubitemid 46963472)
3. Cox ME, Gleave ME, Zakikhani M, et al,. Insulin receptor expression by human prostate cancers. Prostate 2009; 69: 33-40
4. Williams GP,. The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. Eur J Cancer Prev 2010; 19: 256-71
5. López Fontana C, Maselli Artola ME, Vanrell Rodríguez MC, Di Milta Monaco NA, Pérez Elizalde R, López Laur JD,. [Advances on the influence of adipose tissue on prostate cancer]. Actas Urol Esp 2009; 33: 242-8
6. Wallström P, Bjartell A, Gullberg B, Olsson H, Wirfält E,. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer 2009; 100: 1799-805
7. MacInnis RJ, English DR,. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006; 17: 989-1003 (Pubitemid 44290764)
8. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG,. Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 1417-21 (Pubitemid 38031743)
9. Maserejian NN, Giovannucci EL, McKinlay JB,. Dietary macronutrients, cholesterol, and sodium and lower urinary tract symptoms in men. Eur Urol 2009; 55: 1179-89
10. Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A,. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007; 51: 199-206 (Pubitemid 44821513)
11. Amling CL, Riffenburgh RH, Sun L, et al,. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22: 439-45 (Pubitemid 41079772)
12. Freedland SJ, Wen J, Wuerstle M, et al,. Obesity is a significant risk factor for prostate cancer at the time of biopsy. Urology 2008; 72: 1102-5
13. Freedland SJ, Sun L, Kane CJ, et al,. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int 2008; 102: 969-74
14. Calle EE,. Obesity and cancer. BMJ 2007; 335: 1107-8 (Pubitemid 350247271)
15. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38 (Pubitemid 36459468)
16. Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW,. Obese men have higher-grade and larger tumors: an analysis of the Duke Prostate Center database. Prostate Cancer Prostatic Dis 2009; 12: 259-63
17. Heidenreich A, Aus G, Bolla M, et al,. [EAU guidelines on prostate cancer]. Actas Urol Esp 2009; 33: 113-26
18. Schmid HP, McNeal JE, Redwine EA, Freiha FS, Stamey TA,. [Systematic morphometry of radical prostatectomy samples. A guideline for general practice]. Helv Chir Acta 1992; 59: 471-6
19. Siddiqui SA,. Obesity and prostate cancer: an insight into postmodern medicine. J Urol 2009; 182: 14-5
20. Rundle AG, Neugut AI,. Modeling the effects of obesity and weight gain on PSA velocity. Prostate 2009; 69: 1573-8
21. Briganti A, Karakiewicz PI, Chun FK, et al,. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection. Int J Urol 2009; 16: 676-81
22. Loeb S, Yu X, Nadler RB, et al,. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? J Urol 2007; 177: 102-6 (Pubitemid 44895330)
23. Isbarn H, Jeldres C, Budäus L, et al,. Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series. Urology 2009; 73: 615-9
24. Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR,. The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol 2009; 182: 112-7
25. Murthy NS, Mukherjee S, Ray G, Ray A,. Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies. J Postgrad Med 2009; 55: 45-54
26. López Fontana CM, Recalde Rincón GM, Messina Lombino D, Uvilla Recupero AL, Pérez Elizalde RF, López Laur JD,. [Body mass index and diet affect prostate cancer development]. Actas Urol Esp 2009; 33: 741-6
27. Bañez LL, Hamilton RJ, Partin AW, et al,. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275-80 (Pubitemid 350146217)
28. López Fontana CM, Maselli Artola ME, Di Milta Monaco N, et al,. [Influence of leptin and adiponectin on prostate cancer]. Arch Esp Urol 2009; 62: 103-8
29. Gross M, Ramirez C, Luthringer D, et al,. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients. Prostate 2009; 69: 520-7
30. Nandeesha H,. Insulin: a novel agent in the pathogenesis of prostate cancer. Int Urol Nephrol 2009; 41: 267-72